Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cancer and cardiac diseases
3.2.1.2 Technological advances and innovation in products
3.2.1.3 Growing awareness towards preventive healthcare and disease screening programs
3.2.1.4 Favorable government initiatives
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increasing use of refurbished products
3.2.2.2 High cost associated with the products
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Company matrix analysis
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Modality, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Computed tomography
5.3 MRI
5.4 Ultrasound
5.5 Nuclear medicine
5.6 X-Ray
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Diagnostic
6.3 Therapeutic
Chapter 7 Market Estimates and Forecast, By Procedure, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Coronary angiography
7.3 Peripheral angiography
7.4 Neurovascular angiography
7.5 Vascular ultrasound
7.6 Microangiography
7.7 Cerebral angiography
7.8 Other procedures
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic imaging centers
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Carestream Health
10.3 GE HealthCare Technologies Inc.
10.4 Hitachi, Ltd.
10.5 Hologic, Inc.
10.6 Koninklijke Philips N.V.
10.7 SAMSUNG ELECTRONICS Co., Ltd
10.8 Shimadzu Corporation
10.9 Siemens Healthineer AG
10.10 Terumo Corporation
